首页> 外文期刊>Indian drugs >ANALYTICAL METHOD DEVELOPMENT AND VALIDATION STUDIES FOR THE ESTIMATION OF ASPIRIN, CLOPIDOGREL BISULPHATE AND ROSUVASTATIN CALCIUM IN FIXED DOSE COMBINATION (CAPSULE) BY UV SPECTROSCOPY
【24h】

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION STUDIES FOR THE ESTIMATION OF ASPIRIN, CLOPIDOGREL BISULPHATE AND ROSUVASTATIN CALCIUM IN FIXED DOSE COMBINATION (CAPSULE) BY UV SPECTROSCOPY

机译:UV光谱法测定固定剂量组合(胶囊)估计阿司匹林,氯吡格雷磷酸盐钙素钙的分析方法开发及验证研究

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, accurate and precise UV spectroscopy method has been developed for the simultaneous estimation of aspirin, rosuvastatin calcium and clopidogrel bisulphate in fixed dose combination (capsule). The third order derivative spectra were used and 290.36 nm, 243.84 nm and 256.16 nm were selected as detection wavelengths. A linear calibration curve was obtained in the concentration range of 20-100 mug/mL for aspirin; 6-20 mug/mL for rosuvastatin calcium and 10-100 mug/mL for clopidogrel bisulphate. The developed method was validated as per the ICH guidelines Q2(R1) for linearity, range, accuracy, precision, robustness, LOD, LOQ and system suitability.
机译:已经开发了一种简单,准确和精确的UV光谱法,用于同时估计Aspirin,Rosuvastatin钙和Clopidogrel丙烯酸盐在固定剂量组合(胶囊)中的二硫酸盐。 使用第三阶衍生光谱,选择290.36nm,243.84nm和256.16nm作为检测波长。 在Aspirin的20-100杯/ ml的浓度范围内获得线性校准曲线; 6-20 mug / ml用于罗苏伐他汀钙和10-100杯/ ml用于氯吡格雷脱硫酸盐。 根据ICH指南Q2(R1)验证开发的方法,用于线性,范围,精度,精度,鲁棒性,LOD,LOQ和系统适用性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号